Document Detail

Comparative efficacy of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double-blind, within-patient, placebo-controlled study.
MedLine Citation:
PMID:  8520806     Owner:  NLM     Status:  MEDLINE    
Sixty female out-patients suffering from moderate to severe primary dysmenorrhea, aged 14-40 years (mean 27 years), entered this randomized, double-blind, 3-period, within-patient study, evaluating the efficacy and tolerability of diclofenac dispersible 46.5 mg (equivalent to 50 mg of diclofenac sodium), ibuprofen 400 mg and placebo taken up to 4 times daily for a maximum of 3 days. Pain relief was evaluated on a verbal rating scale (0 = none, 1 = slight, 2 = moderate, 3 = considerable, 4 = complete) at 0.5, 1,2,3,4,5 and 6 hours after the first dose; the weighted sum of pain relief scores over the 6-hour observation period was also investigated (TOTPAR-6). Pain intensity was assessed on a verbal rating scale (0 = nil, 1 = mild, 2 = moderate, 3 = severe) at baseline and at the above mentioned time points; the weighted sum of pain intensity differences at each time point was also analyzed (SPID-6). A rescue medication was permitted 1 hour or more after the intake of the test drug: in such cases the last value of pain intensity/relief scores was carried forward and used for the analysis. A global evaluation of efficacy and of trial medication as compared to her usual medication was performed by the patient at the end of each treatment period. Finally, adverse experiences were recorded throughout the study period. Analysis of covariance and Koch's adaptation of the Wilcoxon-Mann-Whitney rank sum test were used, where appropriate, for statistical analysis. Mean TOTPAR-6 values for diclofenac dispersible, ibuprofen and placebo were 16.5, 17.8 and 14.7, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
M Marchini; L Tozzi; R Bakshi; R Pistai; L Fedele
Related Documents :
24323906 - Nonspecific hyper-reactivity and localized allergy: cause of discrepancy between skin p...
22060666 - Influence of freezing method on thaw drip and protein loss of low-voltage electrically ...
22841526 - Hypertonic solution decreases extravascular lung water in cardiac patients undergoing c...
24752726 - Changes in number of water-filled vesicles of choroid plexus in early and late phase of...
9689756 - Grip strength in tennis elbow : long-term results of operative treatment.
17980336 - Graft interposition colpocleisis, perineorrhaphy, and tension-free sling for pelvic org...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  33     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  1995 Sep 
Date Detail:
Created Date:  1996-01-19     Completed Date:  1996-01-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  491-7     Citation Subset:  IM    
Department of Obstetrics and Gynecology, L. Mangiagalli, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage,  pharmacokinetics,  therapeutic use*
Cross-Over Studies
Diclofenac / administration & dosage,  pharmacokinetics,  therapeutic use*
Double-Blind Method
Dysmenorrhea / drug therapy*
Ibuprofen / administration & dosage,  pharmacokinetics,  therapeutic use*
Pain / drug therapy,  etiology
Pain Measurement
Patient Compliance
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 15307-86-5/Diclofenac; 15687-27-1/Ibuprofen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reasons for prescribing cognition enhancers in primary care. Results of a representative survey in L...
Next Document:  Glutathione conjugation with 1-chloro-2,4-dinitrobenzene (CDNB): interindividual variability in huma...